Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

STOP-MSU: Stopping Haemorrhage With Tranexamic Acid for Hyperacute Onset Presentation Including Mobile Stroke Units. A Phase II Randomised, Placebo-controlled, Investigator-driven Trial of Tranexamic Acid Within 2 Hours of Intracerebral Haemorrhage

NCT03385928 is registered in ClinicalTrials.gov with Neuroscience Trials Australia as lead sponsor.

NCT NCT03385928
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03385928 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
STOP-MSU: Stopping Haemorrhage With Tranexamic Acid for Hyperacute Onset Presentation Including Mobile Stroke Units. A Phase II Randomised, Placebo-controlled, Investigator-driven Trial of Tranexamic Acid Within 2 Hours of Intracerebral Haemorrhage
Lead sponsor
Neuroscience Trials Australia
Phase
Phase 2
Overall status
Completed
Start date
March 19, 2018
Completion date
May 28, 2023
Enrollment
201 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

intracerebral haemorrhage